H1-antihistamines and inflammation

Clinical and Experimental Allergy

Volumn 31, Issue 9, 2001, Pages 1341-1343

  Church, M K ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; AZELASTINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CETIRIZINE; CHLORPROMAZINE; DOPAMINE RECEPTOR BLOCKING AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE H1 RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEVOCABASTINE; LORATADINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PROTEIN KINASE C; SEROTONIN ANTAGONIST; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; ANTICHOLINERGIC EFFECT; ANTIINFLAMMATORY ACTIVITY; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL MIGRATION; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; ENZYME ACTIVATION; HISTAMINE RELEASE; HUMAN; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION;

HISTAMINE H1 ANTAGONISTS; HUMANS; INFLAMMATION;

EID: 0034840304     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01195.x     Document Type: Editorial

References (35)

1. Histamine release by antihistamines
2. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine
3. Amitriptylline and asthma
4. The displacement of membrane calcium by a local anaesthetic (chlorpromazine)
5. The membrane actions of anaesthetics and tranquillizers
6. Calcium replacement by cationic amphiphillic drugs from lipid monolayers
7. The stimuli releasing histamine from murine bone marrow-derived mast cells. 1. The presence of P2-purinoceptors
8. Effects of loratadine on cytosolic Ca2+ levels and leukotriene release: Novel mechanisms of action independent of the anti-histamine activity
9. Action of azelastine on intracellular Ca2+ in cultured airway smooth muscle
10. Leukotriene B4 induced steady state calcium rise and superoxide anion generation in guinea pig eosinophils are not related events
11. Inhibition of chemiluminescence in granulocytes and alveolar macrophages by azelastine
12. Biochemical study on anti-inflammatory action of anti-allergic drugs - With regard to NADPH oxidase
13. Effects of anti-allergic drugs on human neutrophil superoxide-generating NADPH oxidase
14. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs
15. Antiallergic activity of loratidine, a nonsedating antihistamine
16. 1-receptor antagonists: Antiallergic effects in vitro
17. Histamine provokes turnover of inositol phospholipids in guinea pig and human airway epithelial cells via an H1-receptor/G protein-dependent mechanism
18. G proteins of the Gq family couple the H2 histamine receptor to phospholipase C
19. Constitutive activity of the histamine H-1 receptor reveals inverse agonism of histamine H-1 receptor antagonists
20. Constitutive activation of NF-κB by the histamine H1 receptor is mediated via Gβγ subunits
21. Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)
22. Hypothetical mechanisms of action of an H1-antihistamine in asthma
23. Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxide
24. Loratadine reduces the expression of ICAM-1
25. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge
26. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: An antiallergic activity
27. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity
28. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis
29. Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro
30. Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow
31. Cloning, expression, and pharmacological characterization of a novel human histamine receptor
32. Discovery of a novel member of the histamine receptor family
33. Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation
34. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late phase allergic cutaneous reactions. A double-blind, placebo-controlled study
35. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETAC. Early treatment of the atopic child